Crysvita savings card: $0 a prescription with commercial insurance

How to pay the least

Ask for the cash price

Crysvita

Crysvita is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Ask your pharmacy for Crysvita’s cash price, and one or two other pharmacies too.
Crysvita’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameCrysvita

Authorized genericburosumab

Regular genericburosumab

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Crysvita?

The original

–

Brand nameThe maker’s card

Kyowa Kirin Cares Co-Pay Assistance Program

Savings card from Kyowa Kirin

No insuranceNeeds insuranceNo cash price listed.

Insurance $0 a prescription

Or call 1-833-552-2737.

In the maker’s words

“Co-Pay Assistance Program had $0 out-of-pocket costs for CRYSVITA.”

From the maker’s offer on crysvita.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Crysvita itself, from the same company, sold without the brand name, and usually for less. For now Crysvita is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Crysvita is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

CRYSVITA is a fibroblast growth factor 23 (FGF23) blocking antibody indicated for:

The treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older.
The treatment of FGF23-related hypophosphatemia in tumor-induced osteomalacia (TIO) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adult and pediatric patients 2 years of age and older.

Source: the FDA label for Crysvita (Kyowa Kirin, Inc.), April 22, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/crysvita/